The agreement calls for Heska to conduct certain research and development activities, to collaborate with RDI on product development and to make certain payments to RDI.

Heska has the exclusive right to sell resulting products in the companion animal health market worldwide.

Rapid Diagnostek said its patented biosensor platform offers results in 60 seconds, without reagents using a low-cost battery powered handheld-sized instrument to detect pathogens, proteins and bio-molecules in whole blood, urine, saliva, water or other liquids.

RDI intends to commercialize diagnostic technology in the veterinary, human, food safety, agricultural, environmental, biohazard, bioterrorism and manufacturing process control testing markets.